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We report amplification of biomolecular recognition signal in lithographically defined silicon
nanochannel devices. The devices are configured as field effect transistors (FET) in the reversed
source-drain bias region. The measurement of the differential conductance of the nanowire chan-
nels in the FET allows sensitive detection of changes in the surface potential due to biomolecu-
lar binding. Narrower silicon channels demonstrate higher sensitivity to binding due to increased
surface-to-volume ratio. The operation of the device in the negative source-drain region demon-
strates signal amplification. The equivalence between protein binding and change in the surface
potential is described.
PACS numbers:
Ultrasensitive recognition of molecules is impor-
tant in basic science, as well as in pharmacol-
ogy and medicine for the analysis of biomarkers [1,
2]. Nanotechnology has made it possible to en-
hance detection sensitivity by using nanowires[3, 4],
nanotubes [5],nanocrystals[6],nanocantilevers[7, 8],and
quantum dots[9]. The signal arising from biomolecu-
lar binding on the surface can alter measurable physi-
cal properties of the nanoscale device such as electrical
conductance with increased sensitivity due to the large
surface-to-volume ratio.
A silicon nanowire can be used as the source-drain
channel of a field effect transistor (FET). In conventional
FETs, lithographic methods are used to fabricate gates
at the bottom, the top, or the side. In addition, the
nanochannel surface can be functionalized with specific
receptor or antibody. In a fluid, the ligand (or antigen)
can bind to the receptor, which results in a change in
the surface charge profile and the surface potential. Es-
sentially, this binding behaves as a field effect. The con-
ductance and the I-V characteristics of the nanowire can
therefore be used to characterize biomolecular binding-
for instance, to determine concentration and bindin dis-
sociation constant. In this letter, we show that charac-
teristics of differential conductance dI/dV can be used for
even higher sensitivity in the field effect due to biomolec-
ular binding. In particular, dI /dV characteristics allow
measurement at low bias, essential for avoiding electrol-
ysis.
In a series of experiments, Lieber and co-workers have
demonstrated the operation of nanowire FET sensors
fabricated with a bottom-up method, using chemically
grown silicon nanowires. These nanowire field-effect sen-
sors show significant advantages of real-time, label-free
and highly sensitive detection of a wide range of ana-
lytes, including proteins, nucleic acids, small molecules,
and viruses in single-element or multiplexed formats[10].
These bottom-up approaches, however, have limitations
arising from the lack of control in materials and fabri-
cation engineering. In contrast, top-down methods of
fabrication by e-beam lithography or submicron optical
lithography enable scalable manufacturing.
Here, we demonstrate that the differential conductance
dI/dV characteristics of silicon nanowire field effect tran-
sistors with width below 200 nm show strong dependence
on gate voltage. We use the peak position of the dI/dV
curve to characterize antibiotin detection with sub-ng/ml
sensitivityby functionalizing the silicon nanowire surface
with biotin. From this measurement, we can extract the
dissociation constant of biotin-antibiotin binding to be
5.2 × 10−10 M, in good agreement with other measure-
ments.
By functionalizing the silicon nanowire surface with bi-
otin, we show that the device can be used to characterize
protein binding. Furthermore, we show equivalence be-
tween the field effect created by the biomolecular binding
and the reference gate voltage. This equivalence allows
the characterization of ligand-receptor binding by de-
termining the calibrated gate voltage dependence rather
than measuring the more cumbersome concentration de-
pendence.
Our devices are fabricated by standard e-beam lithog-
raphy and surface nanomachining. The starting (100)
SOI wafer has a device layer thickness of 100 nm and ox-
ide layer thickness of 380 nm, on a 600 µm boron-doped
substrate. The device-layer volume resistivity ranges
from 10-20 Ω· cm. After patterning the nanowires and
the electrode in separate steps, the structure is etched out
with an anisotropic reactive-ion etch. This process ex-
poses the three surfaces of the silicon nanowire along the
longitudinal direction, resulting in structure with three-
dimensional relief and a large surface-to-volume ratio. Fi-
nally, a layer of Al2O3 (5-20 nm thick) is grown by atomic
layer deposition. A plasti flow cell is used to bathe the
device in a small volume of fluid 20-30 (L) avoiding the
mixing problem of microfluidi channel[11].
The device pictures and measurement configurations
are shown in Fig. 1. The use of parallel nanowires
improves the average signal while maintaining a high
surface-to-volume ratio. A fabricated top gate is used
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FIG. 1: Device configuration. (a) (b) Scanning electron
micrographs of multiple sensor array and single wire. (c)
Schematic of device cross-section view with top gate geometry.
(d) Schematic of cross-sectional view of the device, showing
reference gate geometry.
to characterize currentvoltage relation of the device in
Fig. 1 (c). Small changes in the conductance of the device
are best measured by considering the differential conduc-
tance g(Vds, Vg) =
(
∂Ids
∂V ds
)
with the measurements made
at constant top gate voltage Vg. In biological sensing
measurements (Fig. 1 (d)), an Ag/AgCl reference gate is
used. The conductance is a function of the bias voltage
Vds, the gate voltage Vg, or equivalently the surface po-
tential, which can be changed either by changing Vrg or
the concentration of charged biomolecules[12].
Fig. 2 (a) is the characteristic of the device with a wire
width of 350 nm. Fig 2(c) shows the characteristic I-V
curve for a 80 nm device. In Fig. 2(b) and Fig. 2(d),
each curve corresponds to differential conductance mea-
surements at fixed values of Vg, ranging from -1 to +3 V.
At large negative Vds, all the curves start with a common
nonzero value of g. Such a universal value suggests that
conductance is dominated by the Schottky barrier at the
junction[13]. Fig. 2(b) shows differential conductance for
the 350 nm wire as a function of Vds, which shows a
peak in differential conductance near 0 V. As Vds is in-
creased above a threshold voltage Vth, the slopes of both
I-V characteristic and differential conductance increase.
For the 350 nm wire, the differential conductance peak
positionin Fig. 2(b) is insensitive to Vg. In contrast, the
peak position in Fig. 2(d) is strongly dependent on Vg.
The sensitivity of the conductance peak of the device
with narrower width comes from the threshold voltage
change. In our model, Vth is linearly dependent on the
surface-to-volume ratio
Asur
Vvol
=
(w + 2H)
wHL
=
w + 2H
wH
. (1)
Here, w is the width of the wire, H is the thickness of the
device layer, and L is the length of the wire. The peak
position of the differential conductance at zero top gate
voltage is plotted as a function of the nanowire width
in Fig. 2(e). Following the methods given in Ref.[14],
FIG. 2: Width dependence of the I-V characteristic curve of
the devices. (a) (b) show Ids and dI/dV versus source drain
voltage Vds at different top gate voltage Vg (-1 V to 3 V with 1
V step increase) for 350 nm wires. (c) (d) show Ids and dI/dV
versus Vds at different Vg (-1 V to 3 V with 1 V step increase)
for 80 nm wires. (e) shows |Vpeak| at Vg = 0 V for devices with
different width. Red points is the simulation results used the
model in reference [14]. The inset is differential conductance
as the function of source drain voltage at Vg = 0 V for different
wire widths.
the conductance peak of the dI/dV versus Vds can be
calculated in a semiconductor model. With increased
surface-to-volume ratio, and hence a higher threshold
voltage, the conductance channel is closed at zero bias.
A higher gate voltage, i.e., a larger negative bias volt-
age, is then needed to open the narrow wire channel.
Therefore, the conductance peak shifts to negative drain
voltage (Fig. 2(e), red points).
In the experiment, the reference gate is immersed in
the solution, and a back gate voltage is applied to the
substrate. In an array of sensors, the solution reference
gate voltage Vrg is common to all the nanowires. How-
ever, the source-drain voltage Vds for each nanowire in
the nanosensor array can be controlled individually. In
this more flexible configuration, the high voltage required
for the back gate can be avoided[11]. At the same time,
after channel is opened gradually by Vds, the sensitivity
of the device can be amplified. This naturally implies a
region of operation at negative bias for high sensitivity
measurements.
The signal amplification effect in reverse bias is demon-
strated in protein (antibiotin) measurements. Silicon
nanowires, functionalized with biotinylated bovine serum
albumin, are used to detect antibiotin in 1 mM NaCl and
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FIG. 3: (a) (b) Differential conductance versus time. The
phosphate buffer is first injected, followed by a 100 ng/mL of
anti-biotin in same buffer, with data acquisition being stopped
for 30 s following the injection. The bias is set at Vds = −0.4
V and Vds = −0.9 V, respectively. (c) Change in the differ-
ential conductance of the device introduced by antibiotin at
different Vds (bottom axis, with fixed Vrg = 0.3 V, black solid
squares). Red solid triangles are the data at different Vrg (top
axis, with Vds = 0 V. Inset is the signal noise ratio of the de-
vice at different Vds. (d) Comparison of conductance change
introduced by 5 mV of reference gate voltage change(black
dots, left axis) and 100 ng/mL of antibiotin solution (red tri-
angles, right axis).
1 mM phosphate buffer solution. At the concentration
of salt used in solution, the Debye screening length λd
at room temperature is about 9.6 nm. λd is sufficiently
large that the surface potential is sensitive to protein
binding, but short enough to screen out biomolecules in
solution.11,15 All solutions used in the measurements are
dialyzed to maintain constant ionic strength. The differ-
ential conductance change ∆g due to 100 ng/ml antibi-
otin in the solution is 0.02 ± 0.01 nS at Vds = −0.4 V
(see Fig. 3(a)), while ∆g is 45± 0.1 nS at Vds = −0.9 V
(see Fig. 3(b)). The signal-to-noise ratio increasesfrom 2
to 34 (see Fig. 3(c) inset). The signal due to 100 ng/ml
antibiotin injection is plotted as a function of Vds and
Vrg (see Fig. 3(c)). This plot clearly shows the effect
ofreverse bias amplification.
The change ∆g above, due to concentration change
at fixed reference gate voltage, can be compared to the
change caused by varying the reference gate voltage while
keeping the concentration fixed. An equivalence between
the surface potential change and concentration change
is then established. ∆g introduced by 100 ng/ml ((660
pM) of antibiotin is equivalent to a gate voltage change
of 7.2± 0.3 mV(see Fig. 3(d))
The fundamental advantage of our label-free device ar-
chitecture is the combination of high detection sensitiv-
ity and standard semiconductor-based fabrication tech-
niques, suitable for scalable manufacturing. We operate
the device in the reverse bias region without applying
high voltage to the back gate[11] or to the reference gate
voltage in the solution. Our device configuration allows
device-level signal amplification and the required degree
of control to enable largescale parallel architecture for
detection of multiple target molecules. This combination
is important for any clinical application, including dis-
ease screening, diagnosis, monitoring,and prognosis, all
of which require fast analysis time, small sample volume,
and low cost.
In conclusion, we fabricate silicon nanowire channel
FET sensors by a top-down e-beam lithography method.
Differential conductance characteristics of the devices
show dependence on the source-drain channel width of
the nanoscale sensor. We take advantage of the strong
dependence in the reverse-bias region to demonstrate
amplification of biomolecular binding signal by modu-
lating the top gate voltage. The operation of the de-
vice at low reference gate voltage prevents electrolysis.
By comparing the signal generated by protein binding
with the change in the reference gate voltage, we estab-
lish an equivalence between the effect arising due to the
concentration-dependent surface charge density and the
tunable surface potential in the silicon nanowires.
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